SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Rizzo Manfredi)
 

Sökning: WFRF:(Rizzo Manfredi) > Step-by-step diagno...

  • Penson, Peter E.School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom; Liverpool Centre for Cardiovascular Science, Liverpool, United Kingdom (författare)

Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients : a position paper from the International Lipid Expert Panel (ILEP)

  • Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

  • 2022-03-10
  • John Wiley & Sons,2022
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:umu-203171
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-203171URI
  • https://doi.org/10.1002/jcsm.12960DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:for swepub-publicationtype

Anmärkningar

  • Statin intolerance is a clinical syndrome whereby adverse effects (AEs) associated with statin therapy [most commonly statin-associated muscle symptoms (SAMS)] result in the discontinuation of therapy and consequently increase the risk of adverse cardiovascular outcomes. However, complete statin intolerance occurs in only a small minority of treated patients (estimated prevalence of only 3–5%). Many perceived AEs are misattributed (e.g. physical musculoskeletal injury and inflammatory myopathies), and subjective symptoms occur as a result of the fact that patients expect them to do so when taking medicines (the nocebo/drucebo effect)—what might be truth even for over 50% of all patients with muscle weakness/pain. Clear guidance is necessary to enable the optimal management of plasma in real-world clinical practice in patients who experience subjective AEs. In this Position Paper of the International Lipid Expert Panel (ILEP), we present a step-by-step patient-centred approach to the identification and management of SAMS with a particular focus on strategies to prevent and manage the nocebo/drucebo effect and to improve long-term compliance with lipid-lowering therapy.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Bruckert, EricPitié-Salpetrière Hospital and Sorbonne University, Cardio metabolic Institute, Paris, France (författare)
  • Marais, DavidChemical Pathology Division of the Department of Pathology, University of Cape Town Health Science Faculty, Cape Town, South Africa (författare)
  • Reiner, ŽeljkoDepartment of Internal Medicine, University Hospital Centre Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia (författare)
  • Pirro, MatteoDepartment of Medicine, University of Perugia, Perugia, Italy (författare)
  • Sahebkar, AmirhosseinBiotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Clinic of Cardiology, University Clinical Centre of Kosova, Medical Faculty, University of Prishtina, Prishtina,Kosovo (författare)
  • Bajraktari, GaniUmeå universitet,Avdelningen för medicin,Department of Internal Disease, Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan(Swepub:umu)gaba0006 (författare)
  • Mirrakhimov, ErkinDepartment of Atherosclerosis and Coronary Heart Disease, National Center of Cardiology and Internal Diseases, Bishkek, Kyrgyzstan (författare)
  • Rizzo, ManfrediDepartment of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy; Division of Endocrinology, Diabetes and Metabolism, School of Medicine, University of South Carolina, SC, Columbia, United States (författare)
  • Mikhailidis, Dimitri P.Department of Clinical Biochemistry, University College London Medical School, University College London (UCL), London, United Kingdom (författare)
  • Sachinidis, AlexandrosDepartment of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy; 2nd Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece (författare)
  • Gaita, DanUniversitatea de Medicina si Farmacie Victor Babes, Timisoara, Romania; Clinica de Cardiologie, Institutul de Boli Cardiovasculare Timisoara, Timisoara, Romania (författare)
  • Latkovskis, GustavsPauls Stradins Clinical University Hospital, Riga, Latvia; University of Latvia, Riga, Latvia (författare)
  • Mazidi, MohsenMedical Research Council Population Health Research Unit, University of Oxford, Oxford, United Kingdom; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom (författare)
  • Toth, Peter P.CGH Medical Center, IL, Sterling, United States; Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, MD, Baltimore, United States (författare)
  • Pella, Daniel2nd Department of Cardiology of the East Slovak Institute of Cardiovascular Disease and Faculty of Medicine, PJ Safarik University, Kosice, Slovakia (författare)
  • Alnouri, FahadCardiovascular Prevention Unit, Adult Cardiology Department, Prince Sultan Cardiac Centre Riyadh, Riyadh, Saudi Arabia (författare)
  • Postadzhiyan, ArmanDepartment of General Medicine, Emergency University Hospital ‘St. Anna’, Medical University of Sofia, Sofia, Bulgaria (författare)
  • Yeh, Hung-IDepartment of Medicine, MacKay Medical College, New Taipei City, Taiwan (författare)
  • Mancini, G.B. JohnDepartment of General Medicine, Emergency University Hospital ‘St. Anna’, Medical University of Sofia, Sofia, Bulgaria (författare)
  • von Haehling, StephanDepartment of Cardiology and Pneumology, Heart Center, University of Göttingen Medical Center, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), partner site Göttingen, Göttingen, Germany (författare)
  • Banach, MaciejPolish Moother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland (författare)
  • School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom; Liverpool Centre for Cardiovascular Science, Liverpool, United KingdomPitié-Salpetrière Hospital and Sorbonne University, Cardio metabolic Institute, Paris, France (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of Cachexia, Sarcopenia and Muscle: John Wiley & Sons13:3, s. 1596-16222190-59912190-6009

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy